Skip Navigation
Skip to contents

Endocrinol Metab : Endocrinology and Metabolism

clarivate
OPEN ACCESS
SEARCH
Search

Search

Page Path
HOME > Search
11 "Sampling"
Filter
Filter
Article type
Keywords
Publication year
Authors
Original Articles
The Localization of Microadenoma with Sella Imaging Study and Inferior Petrosal Sinus Sampling in Cushing's Disease.
Jae Seok Jeon, Sang Jeon Choi, Chan Soo Shin, Kyoung Soo Park, Seong Yeon Kim, Bo Youn Cho, Hong Kyu Lee, Chang Soon Koh, Hee Won Jung, Dae Hee Han, Moon Hee Han, Kee Hyun Chang
J Korean Endocr Soc. 1996;11(4):492-499.   Published online November 7, 2019
  • 1,016 View
  • 21 Download
AbstractAbstract PDF
Background
Inferior petrosal sinus sampling(IPSS) is known to be useful for the differential diagnosis of ACTH-dependent Cushings syndrome and for the preoperative lateralization of pituitary microadenoma. We tried to analyze the relative value of IPSS in localization of microadenoma as compared with sella imaging study including computerized tomogram(CT) or magnet resonance imaging(MRI) in Cushings disease. Methods: We reviewed the clinical records of 21 patients with Cushings disease who underwent IPSS and the radiologic study such as sella CT or sella MRI preoperatively followed by transsphenoidal microsurgery. By pathologic examination including immunohistochemistry and postoperative clinical and biochemical evaluation we confirmed the diagnosis of Cushings disease due to pituitary microadenoma in all 21 cases. Results: Sella CT or sella MRI detected microadenoma in 57.1% of cases( =12/21), while recently available dynamic MRI did so in 7 out of S cases. With IPSS the diagnosis of Cushings disease was possible in 90.5% of cases(= 19/21), but accurate lateralization of microadenoma was achieved in only 63.2% of cases( =12/19). IPSS precisely localized the pituitary microadenoma in 6 out of 9 cases whose lesion were not detected by the radiologic study. Of 7 cases in which IPSS failed to localize microadenoma, the radiologic study detected the lesion in 6 cases. Of 5 cases in which IPSS and the radiologic study showed a discrepancy in location of microadenoma, the radiologic study correctly localizaed the lesion in 4 cases and IPSS did so in one case. Conclusion: IPSS is not more reliable than sella imaging study for preoperative localization of microadenoma in Cushings disease. However it might have a complementary role, especially when sella imaging study failed to visualize the lesion.
Close layer
A Clinical study on the diagnesis and Treatment of Cushing's Disease - The significance of bilateral inferior petrosal sinus sampling -.
Seong Yeon Kim, Kyung Soo Park, Bo Youn Cho, Hong Kyu Lee, Jae Seok Jeon, Hyeong Kyu Park, Chang Soon Koh, Hun Ki Min, Heu Won Jeong, Dae Hee Han, Moon Hee Han, Kee Hyun Jang
J Korean Endocr Soc. 1994;9(2):115-120.   Published online November 6, 2019
  • 1,093 View
  • 19 Download
AbstractAbstract PDF
Bilateral inferior petrosal sinus sampling(IPSS) is known to be useful for the differential diagnosis of ACTH-dependent Cushing's syndrome and for the preoperative localization of pituitary microadenomas.To evaluate the usefulness of IPSS, we performed the procedure in the 17 cases of ACTH-dependent Cushing's syndrome including 2 cases of macroadenomas, 6 of them with CRH stimulation test. A inferior petrosal sinus-to-peripheral ACTH ratio of 2:1 or greater(3:1 after CRH stimulation) indicates a pituitary source of ACTH hypersecretion, and a ratio of the ACTH level in one inferior petrosal sinus to the ACTH level in the other of 1:4 or greater lateralizes the microadenomas to that half of the pituitary gland.With these criteria, we diagnosed Cushing's disease in 15 of 17 cases of ACTH-dependent Cushing's syndrome, and localized the lesion in 8 of 13 cases of microadenoma.In conclusion, IPSS with CRH stimulation has high diagnostic accuracy in the differential diagnosis of ACTH-dependent Cushing's syndrome, but still has the limitations on the localization of microadenoma.
Close layer
Clinical Study
Factors Associated with Resolution of Hypertension after Adrenalectomy in Patients with Primary Aldosteronism
Wann Jia Loh, Dawn Shao Ting Lim, Lih Ming Loh, Peng Chin Kek
Endocrinol Metab. 2018;33(3):355-363.   Published online August 14, 2018
DOI: https://doi.org/10.3803/EnM.2018.33.3.355
  • 3,965 View
  • 50 Download
  • 8 Web of Science
  • 8 Crossref
AbstractAbstract PDFPubReader   ePub   
Background

The aim of this study was to investigate the factors associated with resolution of hypertension after adrenalectomy in patients with primary aldosteronism. A secondary aim was to describe our use of the contralateral ratio in adrenal venous sampling (AVS) in the setting of suboptimal successful cannulation rates.

Methods

A retrospective review of patients who underwent AVS followed by unilateral adrenalectomy for primary aldosteronism was performed.

Results

Complete resolution of hypertension and hypokalemia was seen in 17 of 40 patients (42.5%), while a clinical improvement in hypertension was seen in 38 of 40 (95%). Shorter duration of hypertension, mean aldosteronoma resolution score (ARS), and a high ARS of 3 to 5 were associated with resolution of hypertension after adrenalectomy (P=0.02, P=0.02, and P=0.004, respectively). Of the individual components of ARS, only a duration of hypertension of ≤6 years was associated with resolution of hypertension after adrenalectomy (P=0.03).

Conclusion

A shorter duration of hypertension was significantly associated with resolution of hypertension after adrenalectomy in patients with primary aldosteronism.

Citations

Citations to this article as recorded by  
  • Clinical and biochemical outcomes after adrenalectomy for primary aldosteronism in tertiary and quaternary referral centers: data from SOPRANO study
    Luigi Marzano, Claudio Ronco
    Hypertension Research.2024; 47(3): 721.     CrossRef
  • Catheter-based adrenal ablation: an alternative therapy for patients with aldosterone-producing adenoma
    Fang Sun, Xiaoli Liu, Hexuan Zhang, Xunmei Zhou, Zhigang Zhao, Hongbo He, Zhencheng Yan, Yingsha Li, Qiang Li, Yaoming Li, Jun Jiang, Zhiming Zhu, Hongyun Miao, Zhiyong Li, Ping Wei, Min Long, Xiaoli Chen, Xiaoyun Fan, Wuquan Deng, Yangjie He, Qingbin Lia
    Hypertension Research.2023; 46(1): 91.     CrossRef
  • Prognostic models to predict complete resolution of hypertension after adrenalectomy in primary aldosteronism: A systematic review and meta‐analysis
    Luigi Marzano, Amir Kazory, Faeq Husain‐Syed, Claudio Ronco
    Clinical Endocrinology.2023; 99(1): 17.     CrossRef
  • Long-term outcome success after operative treatment for primary aldosteronism
    Omar Picado, Bryan W. Whitfield, Zahra F. Khan, Mohammed Jeraq, Josefina C. Farrá, John I. Lew
    Surgery.2021; 169(3): 528.     CrossRef
  • Outcomes of Adrenalectomy and the Aldosteronoma Resolution Score in the Black and Hispanic Population
    Gustavo Romero‐Velez, Amanda M. Laird, Manuel E. Barajas, Mauricio Sierra‐Salazar, Miguel F. Herrera, Steven K. Libutti, Michael K. Parides, Xavier Pereira, John C. McAuliffe
    World Journal of Surgery.2021; 45(5): 1475.     CrossRef
  • Comparison of cystatin C-based and creatinine-based glomerular filtration rate in the prediction of postoperative residual hypertension in aldosterone-producing adenoma patients after adrenalectomy
    Ching-Way Chen, Cheng-Hsuan Tsai, Chi-Sheng Hung, I-Jung Tsai, Yu-Wei Chiu, Chin-Cheng Chang, Kao-Lang Liu, Shih-Cheng Liao, Vin-Cent Wu, Yen-Hung Lin
    Clinica Chimica Acta.2021; 520: 147.     CrossRef
  • Long-term blood pressure outcomes of patients with adrenal venous sampling-proven unilateral primary aldosteronism
    Xu Meng, Wen-Jun Ma, Xiong-Jing Jiang, Pei-Pei Lu, Ying Zhang, Peng Fan, Jun Cai, Hui-Min Zhang, Lei Song, Hai-Ying Wu, Xian-Liang Zhou, Ying Lou
    Journal of Human Hypertension.2020; 34(6): 440.     CrossRef
  • Update on the Aldosterone Resolution Score and Lateralization in Patients with Primary Aldosteronism
    Eun-Hee Cho
    Endocrinology and Metabolism.2018; 33(3): 352.     CrossRef
Close layer
Review Articles
Adrenal gland
Clinical Guidelines for the Diagnosis and Treatment of Cushing's Disease in Korea
Kyu Yeon Hur, Jung Hee Kim, Byung Joon Kim, Min-Seon Kim, Eun Jig Lee, Sung-Woon Kim
Endocrinol Metab. 2015;30(1):7-18.   Published online March 27, 2015
DOI: https://doi.org/10.3803/EnM.2015.30.1.7
  • 6,713 View
  • 151 Download
  • 10 Web of Science
  • 15 Crossref
AbstractAbstract PDFPubReader   

Cushing's disease (CD) is a rare disorder characterized by the overproduction of adrenocorticotropic hormone due to a pituitary adenoma that ultimately stimulates excessive cortisol secretion from the adrenal glands. Prior to the detection of pituitary adenomas, various clinical signs of CD such as central obesity, moon face, hirsutism, and facial plethora are usually already present. Uncontrolled hypercortisolism is associated with metabolic, cardiovascular, and psychological disorders that result in increased mortality. Hence, the early detection and treatment of CD are not only important but mandatory. Because its clinical manifestations vary from patient to patient and are common in other obesity-related conditions, the precise diagnosis of CD can be problematic. Thus, the present set of guidelines was compiled by Korean experts in this field to assist clinicians with the screening, diagnoses, and treatment of patients with CD using currently available tests and treatment modalities.

Citations

Citations to this article as recorded by  
  • Diet quality and dietary acid load in relation to cardiovascular disease mortality: Results from Fasa PERSIAN cohort study
    Sahar Fereidouni, Najmeh Hejazi, Reza Homayounfar, Mojtaba Farjam
    Food Science & Nutrition.2023; 11(3): 1563.     CrossRef
  • Role of computed tomography in predicting adrenal adenomas with cortisol hypersecretion
    Chan Kyo Kim, Kyung A Kang, Young Lyun Oh, Sung Yoon Park
    The British Journal of Radiology.2023;[Epub]     CrossRef
  • Dietary acid load and mortality from all causes, CVD and cancer: results from the Golestan Cohort Study
    Ehsan Hejazi, Hadi Emamat, Maryam Sharafkhah, Atoosa Saidpour, Hossein Poustchi, Sadaf Sepanlou, Masoud Sotoudeh, Sanford Dawsey, Paolo Boffetta, Christian C Abnet, Farin Kamangar, Arash Etemadi, Akram Pourshams, Akbar Fazeltabar Malekshah, Paul Berennan,
    British Journal of Nutrition.2022; 128(2): 237.     CrossRef
  • Forty Years Together, New Leap Forward! The 40th Anniversary of the Korean Endocrine Society
    Jong Chul Won, Ki-Hyun Baek
    Endocrinology and Metabolism.2022; 37(6): 851.     CrossRef
  • Pituitary adenomas: current principles of diagnosis and treatment
    L. I. Astafyeva, I. V. Chernov, I. V. Chekhonin, E. I. Shults, I. N. Pronin, P. L. Kalinin
    Russian journal of neurosurgery.2021; 22(4): 94.     CrossRef
  • Metabolic changes in serum steroids for diagnosing and subtyping Cushing’s syndrome
    Chang Ho Ahn, Chaelin Lee, Jaeyoon Shim, Sung Hye Kong, Su-jin Kim, Yong Hwy Kim, Kyu Eun Lee, Chan Soo Shin, Jung Hee Kim, Man Ho Choi
    The Journal of Steroid Biochemistry and Molecular Biology.2021; 210: 105856.     CrossRef
  • Application of different variants of endoscopic transphenoidal removal of corticotropinomas in order to increase the frequency and duration of remission
    A. Ashraf, I. V. Chernov, A. N. Shkarubo, M. A. Kutin, D. V. Fomichev, O. I. Sharipov, Yu. Yu. Trunin, D. N. Andreev, A. A. Abdilatipov, L. I. Astafieva, B. Abdali, A. B. Kurnosov, G. E. Chmutin, Kalinin P. L. Kalinin P. L.
    Vestnik nevrologii, psihiatrii i nejrohirurgii (Bulletin of Neurology, Psychiatry and Neurosurgery).2021; (2): 143.     CrossRef
  • Modern aspects of surgery for cushing’s disease
    A. Abdali, L.I. Astafeva, Yu.Yu. Trunin, I.V. Chernov, Yu.G. Sidneva, A.A. Abdilatipov, P.L. Kalinin
    Voprosy neirokhirurgii imeni N.N. Burdenko.2021; 85(4): 111.     CrossRef
  • Pituitary microadenomas — current diagnostic and treatment methods
    L.I. Astafyeva, B.A. Kadashev, Yu.G. Sidneva, I.V. Chernov, P.L. Kalinin
    Voprosy neirokhirurgii imeni N.N. Burdenko.2020; 84(2): 110.     CrossRef
  • Usefulness of prolactin measurement in inferior petrosal sinus sampling with desmopressin for Cushing’s syndrome
    Hamideh Akbari, Mohammad Ghorbani, Maryam Kabootari, Ali Zare Mehrjardi, Mohammad Reza Mohajeri Tehrani, Mojtaba Malek, Mohammad E. Khamseh
    British Journal of Neurosurgery.2020; 34(3): 253.     CrossRef
  • Hormonal aggressiveness according to the expression of cellular markers in corticotroph adenomas
    Jung Soo Lim, Mi-Kyung Lee, Eunhee Choi, Namki Hong, Soo Il Jee, Sun Ho Kim, Eun Jig Lee
    Endocrine.2019; 64(1): 147.     CrossRef
  • Clinical Parameters to Distinguish Silent Corticotroph Adenomas from Other Nonfunctioning Pituitary Adenomas
    Daham Kim, Cheol Ryong Ku, Se Hee Park, Ju Hyung Moon, Eui Hyun Kim, Sun Ho Kim, Eun Jig Lee
    World Neurosurgery.2018; 115: e464.     CrossRef
  • Blood Tests for the Diagnosis of Adrenal Diseases
    Seon-Ah Cha, Sung-Dae Moon
    The Korean Journal of Medicine.2018; 93(6): 532.     CrossRef
  • Choosing wisely: la lista del gruppo di studio Endocrinologia e Malattie del Metabolismo della Società Italiana di Patologia Clinica e Medicina di Laboratorio
    Romolo M. Dorizzi, Anna Ferrari, Marina Vitillo, Beatrice Caruso, Claudio Cocco, Erennio Ciotoli, Federica D’Aurizio, Elisa Esposito, Germana Giannone, Giulio Ozzola, Ottavia Porzio, Emanuela Toffalori, Renato Tozzoli
    La Rivista Italiana della Medicina di Laboratorio - Italian Journal of Laboratory Medicine.2016; 12(2): 81.     CrossRef
  • Surgical management of adrenocorticotropic hormone-secreting pituitary adenomas
    Edwin S Kulubya, Daniel A Donoho, John D Carmichael, Gabriel Zada
    International Journal of Endocrine Oncology.2016; 3(1): 41.     CrossRef
Close layer
Bone Metabolism
Diagnostic Modalities for FGF23-Producing Tumors in Patients with Tumor-Induced Osteomalacia
Seiji Fukumoto
Endocrinol Metab. 2014;29(2):136-143.   Published online June 26, 2014
DOI: https://doi.org/10.3803/EnM.2014.29.2.136
  • 4,653 View
  • 53 Download
  • 25 Web of Science
  • 28 Crossref
AbstractAbstract PDFPubReader   

Fibroblast growth factor 23 (FGF23) is a hormone that is produced by osteocytes and regulates phosphate and vitamin D metabolism through binding to the Klotho-FGF receptor complex. Excessive actions of FGF23 cause several kinds of hypophosphatemic rickets/osteomalacia. Tumor-induced rickets/osteomalacia (TIO) is a paraneoplastic syndrome caused by overproduction of FGF23 from the responsible tumors. Because TIO is cured by complete resection of the causative tumors, it is of great clinical importance to locate these tumors. Several imaging methods including skeletal survey by magnetic resonance imaging and octreotide scintigraphy have been used to identify the tumors that cause TIO. However, none of these imaging studies indicate that the detected tumors are actually producing FGF23. Recently, systemic venous sampling was conducted for locating FGF23-producing tumor in suspected patients with TIO and demonstrated that this test might be beneficial to a subset of patient. Further studies with more patients are necessary to establish the clinical utility of venous sampling in patients with TIO.

Citations

Citations to this article as recorded by  
  • Progression of phosphaturic mesenchymal tumor in the femoral bone during treatment with burosumab: A case report
    Koichi Okajima, Hiroshi Kobayashi, Hayata Suzuki, Liuzhe Zhang, Yuki Ishibashi, Yusuke Tsuda, Munetoshi Hinata, Yoichi Yasunaga, Tetsuo Ushiku, Yuji Nakamoto, Yasuhiro Takeuchi, Sakae Tanaka
    JOS Case Reports.2024; 3(1): 6.     CrossRef
  • Extended curettage for tumour-induced osteomalacia in the bone
    Koichi Okajima, Hiroshi Kobayashi, Nobuaki Ito, Hajime Kato, Yuki Ishibashi, Liuzhe Zhang, Yusuke Tsuda, Sakae Tanaka
    Japanese Journal of Clinical Oncology.2024; 54(4): 463.     CrossRef
  • Patterns of symptoms and insufficiency fractures in patients with tumour-induced osteomalacia
    Hiroshi Kobayashi, Nobuaki Ito, Yudai Nakai, Hajime Katoh, Koichi Okajima, Liuzhe Zhang, Yusuke Tsuda, Sakae Tanaka
    The Bone & Joint Journal.2023; 105-B(5): 568.     CrossRef
  • Tumor-induced Osteomalacia: A Systematic Review and Individual Patient’s Data Analysis
    Domenico Rendina, Veronica Abate, Giuseppe Cacace, Lanfranco D’Elia, Gianpaolo De Filippo, Silvana Del Vecchio, Ferruccio Galletti, Alberto Cuocolo, Pasquale Strazzullo
    The Journal of Clinical Endocrinology & Metabolism.2022; 107(8): e3428.     CrossRef
  • Novel Small Molecule Fibroblast Growth Factor 23 Inhibitors Increase Serum Phosphate and Improve Skeletal Abnormalities in Hyp Mice
    Zhousheng Xiao, Jiawang Liu, Shih-Hsien Liu, Loukas Petridis, Chun Cai, Li Cao, Guangwei Wang, Ai Lin Chin, Jacob W. Cleveland, Munachi O. Ikedionwu, Jesse D. Carrick, Jeremy C. Smith, Leigh Darryl Quarles
    Molecular Pharmacology.2022; 101(6): 408.     CrossRef
  • Identification of Small-Molecule Inhibitors of Fibroblast Growth Factor 23 Signaling via In Silico Hot Spot Prediction and Molecular Docking to α-Klotho
    Shih-Hsien Liu, Zhousheng Xiao, Sambit K. Mishra, Julie C. Mitchell, Jeremy C. Smith, L. Darryl Quarles, Loukas Petridis
    Journal of Chemical Information and Modeling.2022; 62(15): 3627.     CrossRef
  • Osteomalacia oncogénica secundaria a tumor mesenquimal fosfatúrico del pie
    Sandra Garrote-Corral, Walter Alberto Sifuentes-Giraldo, María Eugenia Reguero-Callejas, Mónica Vázquez-Díaz
    Revista Colombiana de Reumatología.2020; 27(3): 210.     CrossRef
  • Hypophosphataemic Rickets: Similar Phenotype of Different Diseases
    Francisco de la Cerda-Ojeda, Juan D. González-Rodríguez, Leire Madariaga, Guillermo Martínez-Díaz-Guerra, María L. Matoses-Ruipérez
    Advances in Therapy.2020; 37(S2): 80.     CrossRef
  • Oncogenic osteomalacia secondary to phosphaturic mesenchymal tumor of the foot
    Sandra Garrote-Corral, Walter Alberto Sifuentes-Giraldo, María Eugenia Reguero-Callejas, Mónica Vázquez-Díaz
    Revista Colombiana de Reumatología (English Edition).2020; 27(3): 210.     CrossRef
  • Tumor-induced Osteomalacia due to a Phosphaturic Mesenchymal Tumor in the Cervical Spine: A Case Report and Literature Review
    Nitish Agarwal, ShashankS Kale, Kalpana Kumari
    Neurology India.2019; 67(5): 1334.     CrossRef
  • Review of paraneoplastic syndromes in children
    Grace MY. Ma, Jeanne S. Chow, George A. Taylor
    Pediatric Radiology.2019; 49(4): 534.     CrossRef
  • Tumor-induced osteomalacia with the culprit lesion located in the palm: a case report
    Yanying Qian, Zhijuan Dai, Cong Zhu, Luya Ruan, Saroj Thapa, Chaoming Wu
    Journal of International Medical Research.2019; 47(5): 2240.     CrossRef
  • Osteomalazie – Klinik, Diagnostik und Therapie
    M. Tiefenbach, M. Scheel, A. Maier, M. Gehlen, M. Schwarz-Eywill, M. Werner, U. Siebers-Renelt, M. Hammer
    Zeitschrift für Rheumatologie.2018; 77(8): 703.     CrossRef
  • Tumor-induced osteomalacia caused by a massive phosphaturic mesenchymal tumor of the acetabulum: A case report
    Kimitaka Nakamura, Masanobu Ohishi, Tomoya Matsunobu, Yasuharu Nakashima, Akio Sakamoto, Akira Maekawa, Yoshinao Oda, Yukihide Iwamoto
    Modern Rheumatology.2018; 28(5): 906.     CrossRef
  • A case report of phosphaturic mesenchymal tumor-induced osteomalacia
    Weiqian Wu, Chongyang Wang, Jianwei Ruan, Feng Chen, Ningjun Li, Fanghu Chen
    Medicine.2017; 96(51): e9470.     CrossRef
  • Localization of Oncogenic Osteomalacia by Systemic Venous Sampling of Fibroblast Growth Factor 23
    Ji-Yeon Lee, Hye-Sun Park, Seunghee Han, Jiyu Kelly Lim, Namki Hong, Sung Il Park, Yumie Rhee
    Yonsei Medical Journal.2017; 58(5): 981.     CrossRef
  • Three-dimensional fluoroscopic navigation-assisted surgery for tumors in patients with tumor-induced osteomalacia in the bones
    Hiroshi Kobayashi, Toru Akiyama, Tomotake Okuma, Yusuke Shinoda, Hiroyuki Oka, Nobuaki Ito, Seiji Fukumoto, Sakae Tanaka, Hirotaka Kawano
    Computer Assisted Surgery.2017; 22(1): 14.     CrossRef
  • Effective localization in tumor-induced osteomalacia using 68Ga-DOTATOC-PET/CT, venous sampling and 3T-MRI
    Shintaro Kawai, Hiroyuki Ariyasu, Yasushi Furukawa, Reika Yamamoto, Shinsuke Uraki, Ken Takeshima, Kenji Warigaya, Yuji Nakamoto, Takashi Akamizu
    Endocrinology, Diabetes & Metabolism Case Reports.2017;[Epub]     CrossRef
  • Prevalence and clinical outcomes of hip fractures and subchondral insufficiency fractures of the femoral head in patients with tumour-induced osteomalacia
    Hiroshi Kobayashi, Nobuaki Ito, Toru Akiyama, Tomotake Okuma, Yuka Kinoshita, Masachika Ikegami, Yusuke Shinoda, Seiji Fukumoto, Sakae Tanaka, Hirotaka Kawano
    International Orthopaedics.2017; 41(12): 2597.     CrossRef
  • Osteomalacia tumoral: un síndrome paraneoplásico emergente
    Guillermo Alonso, Mariela Varsavsky
    Endocrinología y Nutrición.2016; 63(4): 181.     CrossRef
  • Tumour-induced osteomalacia: An emergent paraneoplastic syndrome
    Guillermo Alonso, Mariela Varsavsky
    Endocrinología y Nutrición (English Edition).2016; 63(4): 181.     CrossRef
  • FGFs: crucial factors that regulate tumour initiation and progression
    Qian Jing, Yuanyuan Wang, Hao Liu, Xiaowei Deng, Lin Jiang, Rui Liu, Haixing Song, Jingyi Li
    Cell Proliferation.2016; 49(4): 438.     CrossRef
  • Bone Histology of Two Cases with Osteomalacia Related to Low-dose Adefovir
    Rikako Hiramatsu, Yoshifumi Ubara, Naoki Sawa, Eiko Hasegawa, Masahiro Kawada, Aya Imafuku, Keiichi Sumida, Junichi Hoshino, Kenmei Takaichi
    Internal Medicine.2016; 55(20): 3013.     CrossRef
  • Tumor induced osteomalacia secondary to anaplastic thyroid carcinoma: A case report and review of the literature
    Ejigayehu G. Abate, Victor Bernet, Cherise Cortese, Hillary W. Garner
    Bone Reports.2016; 5: 81.     CrossRef
  • Tumor-induced osteomalacia originating from bones: a report of two cases and literature review
    Zhuo Cai, Qiang Meng, Hanfeng Guan, Qing Yang, Caihong Yang, Jun Xiao
    Oncology and Translational Medicine.2016; 2(2): 69.     CrossRef
  • Tumor-Induced Osteomalacia: an Up-to-Date Review
    Anke H. Hautmann, Matthias G. Hautmann, Oliver Kölbl, Wolfgang Herr, Martin Fleck
    Current Rheumatology Reports.2015;[Epub]     CrossRef
  • Locally aggressive and multifocal phosphaturic mesenchymal tumors: two unusual cases of tumor-induced osteomalacia
    Meghan Higley, Brooke Beckett, Sandra Schmahmann, Elizabeth Dacey, Erik Foss
    Skeletal Radiology.2015; 44(12): 1825.     CrossRef
  • Articles in 'Endocrinology and Metabolism' in 2014
    Won-Young Lee
    Endocrinology and Metabolism.2015; 30(1): 47.     CrossRef
Close layer
Case Report
Adrenal gland
Adrenocorticotropic Hormone-Independent Cushing Syndrome with Bilateral Cortisol-Secreting Adenomas
Eu Jeong Ku, A Ram Hong, Ye An Kim, Jae Hyun Bae, Mee Soo Chang, Sang Wan Kim
Endocrinol Metab. 2013;28(2):133-137.   Published online June 18, 2013
DOI: https://doi.org/10.3803/EnM.2013.28.2.133
  • 3,966 View
  • 44 Download
  • 9 Web of Science
  • 10 Crossref
AbstractAbstract PDFPubReader   

A 48-year-old woman was incidentally found to have bilateral adrenal masses, 2.8 cm in diameter on the right, and 2.3 cm and 1.7 cm in diameter on the left, by abdominal computed tomography. The patient had a medical history of hypertension, which was not being controlled by carvedilol, at a dose of 25 mg daily. She presented with signs and symptoms that suggested Cushing Syndrome. We diagnosed adrenocorticotropic hormone (ACTH)-independent Cushing Syndrome based on the results of basal and dynamic hormone tests. Adrenal vein sampling (AVS) was performed to localize a functioning adrenal cortical mass. AVS results were consistent with hypersecretion of cortisol from both adrenal glands, with a cortisol lateralization ratio of 1.1. Upon bilateral laparoscopic adrenalectomy, bilateral ACTH-independent adrenal adenomas were found. The patient's signs and symptoms of Cushing Syndrome improved after surgery just as the blood pressure was normalized. After surgery, the patient was started on glucocorticoid and mineralocorticoid replacement therapy.

Citations

Citations to this article as recorded by  
  • Recent Advances in the Clinical Application of Adrenal Vein Sampling
    Shan Zhong, Tianyue Zhang, Minzhi He, Hanxiao Yu, Zhenjie Liu, Zhongyi Li, Xiaoxiao Song, Xiaohong Xu
    Frontiers in Endocrinology.2022;[Epub]     CrossRef
  • The role of adrenal venous sampling (AVS) in primary bilateral macronodular adrenocortical hyperplasia (PBMAH): a study of 16 patients
    German Rubinstein, Andrea Osswald, Leah Theresa Braun, Frederick Vogel, Matthias Kroiss, Stefan Pilz, Sinan Deniz, Laura Aigner, Thomas Knösel, Jérôme Bertherat, Lucas Bouys, Roland Ladurner, Anna Riester, Martin Bidlingmaier, Felix Beuschlein, Martin Rei
    Endocrine.2022; 76(2): 434.     CrossRef
  • Concomitant coexistence of ACTH‐dependent and independent Cushing syndrome
    Ach Taieb, Saad Ghada, Gorchène Asma, Ben Abdelkrim Asma, Kacem Maha, Ach Koussay
    Clinical Case Reports.2022;[Epub]     CrossRef
  • The Value of Adrenal Androgens for Correcting Cortisol Lateralization in Adrenal Venous Sampling in Patients with Normal Cortisol Secretion
    Wenjing Zhang, Keying Zhu, Hongyun Li, Yan Zhang, Dalong Zhu, Xuebin Zhang, Ping Li
    International Journal of Endocrinology.2019; 2019: 1.     CrossRef
  • Adrenal venous sampling in patients with ACTH-independent hypercortisolism
    Eleni Papakokkinou, Hugo Jakobsson, Augustinas Sakinis, Andreas Muth, Bo Wängberg, Olof Ehn, Gudmundur Johannsson, Oskar Ragnarsson
    Endocrine.2019; 66(2): 338.     CrossRef
  • ACTH-independent Cushing’s syndrome with bilateral cortisol-secreting adrenal adenomas: a case report and review of literatures
    Jia Wei, Sheyu Li, Qilin Liu, Yuchun Zhu, Nianwei Wu, Ying Tang, Qianrui Li, Kaiyun Ren, Qianying Zhang, Yerong Yu, Zhenmei An, Jing Chen, Jianwei Li
    BMC Endocrine Disorders.2018;[Epub]     CrossRef
  • A case of adrenal Cushing’s syndrome with bilateral adrenal masses
    Ya-Wun Guo, Chii-Min Hwu, Justin Ging-Shing Won, Chia-Huei Chu, Liang-Yu Lin
    Endocrinology, Diabetes & Metabolism Case Reports.2016;[Epub]     CrossRef
  • Bilateral Adrenocortical Masses Producing Aldosterone and Cortisol Independently
    Seung-Eun Lee, Jae Hyeon Kim, You-Bin Lee, Hyeri Seok, In Seub Shin, Yeong Hee Eun, Jung-Han Kim, Young Lyun Oh
    Endocrinology and Metabolism.2015; 30(4): 607.     CrossRef
  • Brief Review of Articles in 'Endocrinology and Metabolism' in 2013
    Won-Young Lee
    Endocrinology and Metabolism.2014; 29(3): 251.     CrossRef
  • A Case of Bilateral ACTH-independent Adrenal Adenomas with Cushing's Syndrome Treated by Ipsilateral Total and Contralateral Partial Laparoscopic Adrenalectomy
    Seung Ah Park, Dong min Jung, Soon young Kim, Nan Young Choi, Tae-jun Kim, Yong kyun Kim, Seong kyun Na, Chul Sik Kim, Seong Jin Lee, Sung-Hee Ihm, Jun Goo Kang
    The Korean Journal of Obesity.2013; 22(4): 254.     CrossRef
Close layer
Original Articles
The Clinical Implication and Problems of Adrenal Vein Sampling in Patients with Primary Aldosteronism.
Jie Seon Lee, Mi Yeon Kang, Sang Wan Kim, Chan Soo Shin, Seong Yeon Kim, Jin Wook Chung
J Korean Endocr Soc. 2007;22(6):428-435.   Published online December 1, 2007
DOI: https://doi.org/10.3803/jkes.2007.22.6.428
  • 2,180 View
  • 21 Download
  • 2 Crossref
AbstractAbstract PDF
BACKGROUND
Recently, the significance of primary aldosteronism is being recognized due to an increase in its incidence and its complications. However, it is difficult to differentiate primary aldosteronism based on radiological studies as the size of an aldosterone producing adenoma (APA) is small, and nonfunctioning adrenal incidentalomas are common. Adrenal vein sampling (AVS) has been considered as the gold standard for differentiating an aldosterone producing adenoma (APA) from bilateral idiopathic adrenal hyperplasia (BAH). The clinical implications and problems associated with AVS have not yet been reported in Korea. METHOD: Clinical data of 28 patients with primary aldosteronism who had undergone AVS in a hospital from 1995 to 2006 were retrospectively analyzed. RESULT: The study group comprised 13 males (46.4%) and 15 females (53.5%), with a mean age of 44.5 +/- 11.9 years. Clinical data indicated that 19 patients (67.9%) had APA and nine patients (32.1%) had BAH. AVS data demonstrated that 11 patients had APA and five patients had BAH. Two patients were not diagnosed despite successful AVS. AVS was not successful in 10 patients (37.5%); AV catheterization failed in two patients, was not selective in seven patients on the right side, and was not selective in one patient on the left side. CONCLUSION: AVS was helpful in primary aldosteronism patients with inconclusive CT and MRI findings. Selectivity of AVS should be appropriately assessed because of the technical problem of selective catheterization.

Citations

Citations to this article as recorded by  
  • Bilateral Adrenocortical Masses Producing Aldosterone and Cortisol Independently
    Seung-Eun Lee, Jae Hyeon Kim, You-Bin Lee, Hyeri Seok, In Seub Shin, Yeong Hee Eun, Jung-Han Kim, Young Lyun Oh
    Endocrinology and Metabolism.2015; 30(4): 607.     CrossRef
  • Primary Aldosteronism
    Sang Wan Kim
    Korean Journal of Medicine.2012; 82(4): 396.     CrossRef
Close layer
Diagnostic Value of 1microgram Rapid ACTH Stimulation Test According to the Timing of Sampling of Serum Cortisol in Patients with Suspected Central Adrenal Insufficiency.
Sang Wan Kim, Young Min Cho, Do Joon Park, Chan Soo Shin, Kyung Soo Park, Seong Yeon Kim, Bo Youn Cho, Hong Kyu Lee
J Korean Endocr Soc. 2004;19(1):33-41.   Published online February 1, 2004
  • 1,238 View
  • 20 Download
AbstractAbstract PDF
BACKGROUND
Traditional testing of the hypothalamic-pituitary-adrenal axis function has essentially relied upon the insulin tolerance test or the metyrapone test(both tests are not only uncomfortable, but are also dangerous). The standard ACTH stimulation test uses an extremely supra-physiologic amount(250f microgram) of ACTH to evaluate a physiological response, which may result in a false normal response. The 1microgram rapid ACTH stimulation test is more physiological and more sensitive than the standard test, but there exist much controversy about when the serum cortisol should be measured or what the most appropriate cut-off point is for normality or whether the 1microgram ACTH commercial solution is needed. The aims of this study were to investigate 1) whether 1microgram of ACTH is an appropriate amount to stimulate the adrenal gland of patients that have suspected central adrenal insufficiency compared with insulin tolerance test(ITT) and 2) the diagnostic value of the 1microgram rapid ACTH stimulation test according to timing of sampling of serum cortisol. METHODS: In order to evaluate the dose-response relationship between ACTH and cortisol, we performed the ITT in 77 patients with suspected central adrenal insufficiency with serial measurements of serum cortisol and plasma ACTH. We drew the blood samples in 10 min intervals between 10 and 60 min after the administration of 1microgram ACTH in 39 patients with central adrenal insufficiency and in 38 pituitary control patients with pituitary. ITT was used to confirm the diseases for the patients of central adrenal insufficiency, but for pituitary control patients, the ITT indicated normality in the patients. Also, all subjects underwent the 250microgram rapid ACTH stimulation test, and we compared the diagnostic value of the 1microgram ACTH stimulation test with the 250microgram test. RESULTS: 1) The plasma ACTH level after the 1microgram ACTH stimulation test, even if it was be assumed as approximately 300pg/mL, was expected to be sufficient enough to stimulate the adrenal cortex normally(serum cortisol levels >18microgram/dL) compared to the plasma ACTH level in the ITT. 2) The sensitivity and specificity of the 1microgram rapid ACTH stimulation test was highest with 92.3% and 84.2%, respectively, when serum cortisol levels were measured at 20, 30, and 40 min after the ACTH injection. The 1microgram rapid ACTH stimulation test was more sensitive than the 250microgram ACTH test(sensitivity: 92.3%, specificity: 71.8%). CONCLUSION: The 1microgram rapid ACTH stimulation test was more sensitive test in patients with suspected central adrenal insufficiency, and blood samples for cortisol levels should be drawn at 20, 30, and 40 min after ACTH administration.
Close layer
Case Report
A Case of Raymond-Cestan Syndrome Caused by Inferior Petrosal Sinus Sampling.
Dong Hyeok Cho
J Korean Endocr Soc. 2003;18(1):73-78.   Published online February 1, 2003
  • 1,222 View
  • 37 Download
AbstractAbstract PDF
Inferior petrosal sinus sampling (IPSS) plays an important role in the assessment of patients with ACTH-dependent Cushing's syndrome. IPSS has been described as an innocuous, essentially risk-free procedure. Neurological complications associated with IPSS are rare. Previously reported neurological complications include brain stem infraction, pontine hemorrhage and subarachnoid hemorrhage. A 26-year-old woman was admitted to the hospital because of a moon face and a buffalo hump. A MRI showed a suspicious, but uncertain, area on the left side of the sella turcica. IPSS was performed as an appropriate means of providing more information about the side of the ACTH source. Immediately after the procedure, the woman experienced double vision, caused by a complete sixth nerve palsy of the left eye, together with a contralateral hemiparesis. From a clinical point of view, abducens nerve palsy and contralateral hemiparesis corresponded to Raymond-Cestan syndrome. I report a case of Raymond-Cestan syndrome, following petrosal sinus sampling in a female patient with ACTH-dependent Cushing's syndrome. To the best of our knowledge, this complication associated with petrosal sinus sampling has only been described in one previous case report. Although IPSS may provide essential information in the investigation of Cushing's syndrome, the possibility of very occasional but devastating complications should be remembered.
Close layer
Original Articles
Diagnosis of Cushing's Disease by Inferior Petrosal Sinus Sampling (IPSS): Evidence of False Negative Results.
Seon Hwa Lee, Hyeon Jeong Jeon, Sun Hee Park, Sun Wook Kim, Do Joon Park, Kyong Soo Park, Seong Yeon Kim, Bo Youn Cho, Hong Kyu Lee
J Korean Endocr Soc. 1999;14(3):483-492.   Published online January 1, 2001
  • 1,074 View
  • 24 Download
AbstractAbstract PDF
BACKGROUND
While inferior petrosal sinus sampling (IPSS) correctly diagnoses pituitary dependent Cushings syndrome if a significant ratio of plasma ACTH between the IPS and the peripheral blood is demonstrated, little has been said about the significance of a negative ratio in Cushings disease (e.g. false negative result). We evaluated the results of IPSS with Cushings disease, and compared them with imaging findings through transsphenoidal surgery. METHODS: 29 patients with Cushings disease underwent transsphenoidal examination of the pituitary gland from 1989 to 1998 at Seoul National University Hospital were evaluated. We compared the results of IPSS and imaging findings with sellar CT or dynamic MRI. The ratio of the ACTH concentrations at the IPS and in the peripheral blood (IPS:P ratio) and the ratio of the ACTH concentrations between the IPSs (interpetrosal ratio) were calculated before and after CRH infusion. RESULTS: With IPSS the diagnosis of Cushings disease was possible in 90% (26/29), and 3 cases in whom IPSS did not show significant IPS:P ACTH ratio were confirmed to be Cushings disease through hemihypophysectomy of lesion suspected by sellar dynamic MRI and achieved remission after operation (e.g. false negative result of diagnosis for Cushings disease by IPSS). However, accurate localization of microadenoma was achieved in only 59% (17/29). Imaging study detected microadenoma in 76% (22/29) and correctly localized in 66% (19/29). Both IPSS and imaging study precisely localized the pituitary microadenoma in 10 (34.5%) cases of 29 cases and a discrepancy between two studies existed in 7 (24.1%) cases in which the imaging study correctly localized microadenoma in 6 cases and IPSS in 1 case. CONCLUSION: Only when a significant IPS:P ACTH ratio is present can Cushings disease be established by IPSS. The absence of a significant IPS:P ACTH ratio does not necessarily imply ectopic secretion of ACfH, nor does it exclude Cushings disease. The results of lateralization by IPSS do not remove the need for transsphenoidal examination of the sella turcica because false negative result can be. IPSS and radiologic study should be complementary used in diagnosis of Cushings disease and localization of microadenoma, as IPSS can be used when sellar imaging study failed to visualize the lesion and hemihypophysectomy of suspected lesion by imaging study can be considered when IPSS did not show significant ratio of ACTH.
Close layer
Primary Aldosteronism Due to Aldosterone Producing Adenama in the Presence of Contralateral Nonfunctioning Adenama.
Ho Young Son, Eun Ah Kim, Jin Il Kwon, Young Joon Kim, Won Ho Chung, Kyung Rim Choi, Sang Jin Choi, Hye Young Park, Moon Ho Kang
J Korean Endocr Soc. 1998;13(2):223-229.   Published online January 1, 2001
  • 1,065 View
  • 19 Download
AbstractAbstract PDF
Primary aldosteronism is in most cases due either to a unilateral adrenal adenama or to a bilateral hyperplasia of the adrenal cortex. But, a few of bilateral adrena1 tumors in primary aldosteronism also have been reported. In these cases, it is important to differentiate the bilateral aldosterone producing adenomas from the unilateral aldosteronoma in the presence of a contralateral nonhmctioning adenoma for marking a treatment plan. We report a case of primary aldosteronism due to a unilateral aldosteronoma in the presence of a contralateral nonfunctioning adenoma. Abdominal CT sean revealed bilateral adrenal tumors, of which the functioning one was successfully localized using adrenal scintigraphy and selective adrenal venous sampling.
Close layer

Endocrinol Metab : Endocrinology and Metabolism